
Opinion|Videos|May 1, 2024
Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis
Selina McGee, OD, FAAO, examines the prevalence, primary symptoms, quality of life impact, and the issues of underdiagnosis and misdiagnosis surrounding Demodex blepharitis in the United States.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Navitus launches GLP-1 drug management programs
3
Deborah Dempsey, Pharm.D., MBA, RPh, on 340B discounts vs. rebates | PBMI 2026
4
Judi Health, Employers Health team up to launch new PBM solution
5
















